title: Comparison of TR Band™ and VasoStat™ Hemostasis Devices following Transpedal Catheterization for Lower Extremity Revascularization for Peripheral Arterial Disease.
abstract: BACKGROUND
  Transpedal access is increasingly utilized for peripheral vascular catheterization. There is a paucity of data on the use of radial hemostasis devices as an alternative to manual compression for achievement of hemostasis after this approach.
  
  
  OBJECTIVE
  To compare safety and efficacy of two hemostasis devices following transpedal catheterization for lower extremity revascularization for peripheral arterial disease.
  
  
  METHODS
  A consecutive cohort of patients with bilateral Rutherford 2-5 disease who underwent transpedal catheterization for peripheral vascular interventions were retrospectively analyzed. In each patient, retrograde tibial artery access was obtained, a 4 French sheath was placed, and all revascularization was performed via tibial access. In all patients, a TR Band™ (Terumo Medical, n = 215) and/or VasoStat™ (Forge Medical, n = 99) were used to apply puncture site compression, following removal of the tibial sheath until hemostasis was achieved. Safety and efficacy of each device was compared.
  
  
  RESULTS
  Puncture site hemostasis was achieved in all patients within 2 hours of sheath removal facilitating early discharge. Two access site pseudoaneurysms occurred within 30 days of revascularization, one of which followed TR Band™ placement and the other following VasoStat™ placement (P = 0.53). Each patient was successfully treated with ultrasound-guided thrombin injection. Loss of access site patency by duplex ultrasound occurred in 2 patients following the TR Band™ and a single patient following the VasoStat™ (P = 1.0).
  
  
  CONCLUSIONS
  Both the TR Band™ and the VasoStat™ were effective in achieving hemostasis following transpedal catheterization with low rates of complications.
authors.affiliation: Chinatown Cardiology, P.C., New York, New York.|Mount Sinai Beth Israel, New York, New York.
authors.forename: Tak W
authors.initials: TW
authors.lastname: Kwan
authors.affiliation: Mount Sinai Beth Israel, New York, New York.
authors.forename: Apurva
authors.initials: A
authors.lastname: Patel
authors.affiliation: Mount Sinai Beth Israel, New York, New York.
authors.forename: Roosha
authors.initials: R
authors.lastname: Parikh
authors.affiliation: Mount Sinai Beth Israel, New York, New York.
authors.forename: Uschi
authors.initials: U
authors.lastname: Auguste
authors.affiliation: Mount Sinai Beth Israel, New York, New York.
authors.forename: Hugo
authors.initials: H
authors.lastname: Rosero
authors.affiliation: Chinatown Cardiology, P.C., New York, New York.|Mount Sinai Beth Israel, New York, New York.
authors.forename: Yili
authors.initials: Y
authors.lastname: Huang
authors.affiliation: Chinatown Cardiology, P.C., New York, New York.|Mount Sinai Beth Israel, New York, New York.
authors.forename: Michael
authors.initials: M
authors.lastname: Liou
authors.affiliation: Mount Sinai Beth Israel, New York, New York.
authors.forename: Justin
authors.initials: J
authors.lastname: Ratcliffe
authors.affiliation: Mount Sinai Beth Israel, New York, New York.
authors.forename: Joseph
authors.initials: J
authors.lastname: Puma
mesh_terms: D000368:Aged; D017541:Aneurysm, False / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D002406:Catheterization, Peripheral / Q000009:adverse effects / Q000379:methods; D057186:Comparative Effectiveness Research; D005260:Female; D006488:Hemostasis, Surgical / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D006489:Hemostatic Techniques / Q000295:instrumentation*; D006801:Humans; D035002:Lower Extremity / Q000098:blood supply; D008297:Male; D058729:Peripheral Arterial Disease / Q000175:diagnosis / Q000601:surgery; D011183:Postoperative Complications / Q000175:diagnosis / Q000517:prevention & control; D016909:Tibial Arteries / Q000601:surgery*; D016896:Treatment Outcome